Applicants,Chemical_Name,Funding_requested_for,Pharmaceutical,Priority_List,Schedules,Therapeutic_group
EISAI NEW ZEALAND LIMITED,Rufinamide,Developmental and epileptic encephalopathies,Rufinamide (INOVELONÂ®),Options for investment,Community and Hospital,Nervous System
